The Short and Long-term Cardiovascular Consequences of Critical Illness: The C3 Study
NCT ID: NCT04545437
Last Updated: 2023-04-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
80000 participants
OBSERVATIONAL
2020-08-10
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Readmission to Intensive Care Unit After Cardiac Surgery in Heart Hospital of Assiut University : Risk Factors .Reasons and Early Out Come
NCT07083297
Risk Modelling for Quality Improvement in the Critically Ill: Making Best Use of Routinely Available Data
NCT02454257
Evaluation of Patients With Critical Illness
NCT00100217
ICU Trial in Critical Ill COVID-19 Patients
NCT04349982
French and EuRopean Outcome Registry in Intensive Care Unit
NCT01367093
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study Participants: Adult patients admitted to a general adult intensive care unit at one or more of the study sites between 2006 and 1st of August 2023.
Objectives:
To determine the short and long-term cardiovascular consequences of critical illness and identify in-ICU factors that affect them.
To identify the risk factors for new-onset atrial fibrillation/flutter occurring during critical illness.
To study the association between poor cardiovascular function during critical illness and long-term cardiovascular disease.
This study will provide new knowledge about the associations between baseline cardiovascular risk, the disease resulting in ICU admission and therapies / events on ICU with subsequent major adverse cardiac events (MACE), to allow the ongoing risk of these events to be determined. If clinicans can idetnify who is at risk, then risk factors can potentially be modified .
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ICU
Patients treated on a general adult intensive care unit
Admission to ICU
Exposure is admission to an Intensive Care Unit
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Admission to ICU
Exposure is admission to an Intensive Care Unit
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to an intensive care unit at a study site from 2006 onwards
Exclusion Criteria
* Patients who inform us directly that they don't wish their records used in this research study
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oxford
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Watkinson
Role: STUDY_DIRECTOR
University of Oxford
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royal Berkshire NHS Foundation Trust
Reading, Berkshire, United Kingdom
Oxford University Hospitals
Oxford, Oxfordshire, United Kingdom
Imperial College Healthcare NHS Trust
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ian Rechner
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
Critical Care Research Group main website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Oxford Rec C
Identifier Type: OTHER
Identifier Source: secondary_id
Confidentiality Advisory Group
Identifier Type: OTHER
Identifier Source: secondary_id
PID14762
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.